GO:0007260 tyrosine phosphorylation of STAT protein: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007260 describes the covalent addition of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.
• This modification is a prerequisite for STAT dimerization, nuclear translocation, and transcriptional activation of cytokine-responsive genes.
• JAK kinases are the principal enzymes that catalyze tyrosine phosphorylation of STAT proteins downstream of cytokine receptors.
• Tyrosine phosphorylation of STAT proteins is required for functional activation of disulfide-containing constitutively active STAT mutants.
• Flow cytometric analysis of STAT phosphorylation is a standard method for quantifying this post-translational modification in single cells.
• Dysregulated tyrosine phosphorylation of STAT proteins contributes to cancer, immune disorders, and infectious disease pathology.
Description
GO:0007260, tyrosine phosphorylation of STAT protein, is a biological process defined as the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein. STAT proteins are latent cytoplasmic transcription factors that become activated when their tyrosine residues are phosphorylated, typically by Janus kinases (JAKs) associated with cytokine receptors. This event is a central node in cytokine and growth factor signaling, converting extracellular cues into changes in gene expression. Researchers study GO:0007260 because it controls cell proliferation, differentiation, survival, and immune responses, and because its dysregulation is implicated in hematological malignancies, solid tumors, and inflammatory diseases. The process is experimentally tractable: phospho-specific antibodies, flow cytometry, and immunoblotting allow direct detection of tyrosine-phosphorylated STAT proteins. Understanding the molecular requirements for STAT tyrosine phosphorylation, including the role of serine phosphorylation and MAPK pathways, is essential for interpreting cytokine signaling data.
tyrosine phosphorylation of STAT protein At A Glance
| GO ID | GO:0007260 |
|---|---|
| GO term | tyrosine phosphorylation of STAT protein |
| Ontology | biological_process |
| Synonym | tyrosine phosphorylation of Stat1 protein, tyrosine phosphorylation of Stat2 protein, tyrosine phosphorylation of Stat3 protein, tyrosine phosphorylation of Stat4 protein, tyrosine phosphorylation of Stat5 protein, tyrosine phosphorylation of Stat6 protein, tyrosine phosphorylation of Stat7 protein |
| Major function | Covalent addition of a phosphate group to a tyrosine residue of a STAT protein, enabling STAT activation, dimerization, and transcriptional regulation |
| Upstream regulators | JAK kinases, cytokine receptors, and growth factor receptors |
| Modulatory inputs | Serine phosphorylation by MAPK pathways can influence STAT function |
| Detection methods | Phospho-specific immunoblotting, flow cytometry, and immunoprecipitation |
| Disease relevance | Cancer, immune dysregulation, and infectious disease |
What Is GO:0007260?
In simple terms, GO:0007260 is the biochemical event in which a phosphate group is attached to a tyrosine amino acid on a STAT protein. This modification is carried out by kinases, most commonly JAK family kinases, and it converts STAT proteins from an inactive to an active state. The QuickGO definition specifies that the process is the introduction of a phosphate group to a tyrosine residue of a STAT protein. This definition encompasses tyrosine phosphorylation of all STAT family members, including Stat1, Stat2, Stat3, Stat4, Stat5, and Stat6. The modification is reversible and tightly regulated, and it is distinct from serine phosphorylation of STATs, which can modulate transcriptional activity without being required for initial activation.
Why Is tyrosine phosphorylation of STAT protein Important in Cell Biology?
Tyrosine phosphorylation of STAT protein is a decisive step in cytokine and growth factor signal transduction, and it is required for the functional activation of STAT transcription factors. Because this modification controls gene expression programs that govern proliferation, differentiation, apoptosis, and immune effector functions, it is a focal point for understanding both normal physiology and disease. The process is also a therapeutic target: JAK inhibitors and STAT-directed strategies aim to modulate this phosphorylation event in malignancies and inflammatory conditions. In the laboratory, measuring STAT tyrosine phosphorylation is a standard readout for pathway activity, and flow cytometric methods have made it possible to quantify this modification at single-cell resolution. Consequently, GO:0007260 is central to immunology, cancer biology, and drug discovery.
• Required for STAT dimerization and nuclear translocation, which are prerequisites for transcriptional activation.
• Mediates signaling downstream of cytokines such as erythropoietin and thrombopoietin.
• Controls hematopoietic cell proliferation and differentiation, including platelet and erythroid responses.
• Is a biomarker readout for JAK-STAT pathway activity in cancer and immune cells.
• Can be inhibited by pathogens, as shown for enterohaemorrhagic Escherichia coli O157:H7 interference with interferon-gamma-induced STAT-1 phosphorylation.
• Is modulated by probiotics that prevent pathogen-mediated inhibition of STAT-1 tyrosine phosphorylation.
• Serine phosphorylation of STATs, which often depends on MAPK activity, can fine-tune the transcriptional output of tyrosine-phosphorylated STATs.
• Constitutively active STAT mutants still require tyrosine phosphorylation for functional activity, underscoring its non-redundant role.
• Provides a tractable experimental target for phospho-flow and immunoblot assays in drug discovery.
• Dysregulation is linked to hematological malignancies and solid tumors, making it a therapeutic focus.
What Happens During tyrosine phosphorylation of STAT protein?
Receptor activation and JAK recruitment
In simple terms: A cytokine binds its receptor, which brings JAK kinases close enough to activate each other.
Cytokine or growth factor binding induces receptor dimerization or conformational changes that allow JAK kinases to trans-phosphorylate and become active. Activated JAKs then phosphorylate tyrosine residues on the receptor cytoplasmic domain, creating docking sites for STAT proteins. This step is the initiating event that couples extracellular signals to STAT tyrosine phosphorylation.
STAT recruitment and tyrosine phosphorylation
In simple terms: STAT proteins dock onto the activated receptor and get tagged with phosphate groups by JAKs.
STAT proteins are recruited to the receptor via their Src homology 2 (SH2) domains, which recognize phosphotyrosine motifs on the receptor. Once bound, JAK kinases phosphorylate a conserved tyrosine residue near the C-terminus of the STAT protein, which is the defining event of GO:0007260. This phosphorylation is required for functional activation of STAT proteins, including constitutively active disulfide-containing mutants.
Dimerization and nuclear translocation
In simple terms: Phosphorylated STATs pair up and move into the nucleus to turn genes on.
Tyrosine phosphorylation creates a phosphotyrosine motif on one STAT molecule that is bound by the SH2 domain of another STAT molecule, forming a stable dimer. These dimers translocate to the nucleus, where they bind DNA and regulate transcription. Without tyrosine phosphorylation, STAT dimers do not form efficiently and transcriptional activation is impaired.
Serine phosphorylation as a modulatory input
In simple terms: Other kinases can add a second phosphate to STATs on serine residues, which tunes their activity.
In addition to tyrosine phosphorylation, STAT proteins can be phosphorylated on serine residues, often by mitogen-activated protein kinases (MAPKs). Serine phosphorylation can influence STAT-promoter complex formation and transcriptional activity, as shown for STAT-promoter complexes. Erythropoietin-induced STAT serine phosphorylation is regulated by distinct MAPK pathways, illustrating crosstalk between signaling cascades. This serine phosphorylation is not the defining event of GO:0007260 but can modulate the consequences of tyrosine phosphorylation.
Negative regulation and dephosphorylation
In simple terms: The phosphate tags are removed by phosphatases, shutting the signal off.
Tyrosine phosphorylation of STAT proteins is reversible and is terminated by protein tyrosine phosphatases, as well as by suppressor of cytokine signaling (SOCS) proteins that inhibit JAK activity. This negative regulation ensures that STAT activation is transient and tightly controlled. Loss of negative regulation can lead to sustained STAT tyrosine phosphorylation, which is associated with oncogenesis.
Key Genes Involved in GO:0007260 tyrosine phosphorylation of STAT protein
The genes and proteins most directly involved in tyrosine phosphorylation of STAT protein include JAK kinases, STAT family members, cytokine receptors, and regulatory phosphatases.
| Gene | Major Role | Research Relevance |
|---|---|---|
| JAK1 | Tyrosine kinase that phosphorylates STAT proteins downstream of cytokine receptors | Target for JAK inhibitors; knockout models define cytokine-specific STAT activation |
| JAK2 | Tyrosine kinase that phosphorylates STAT5 and STAT3 in hematopoietic signaling | Driver mutations in myeloproliferative neoplasms; key research focus |
| JAK3 | Tyrosine kinase primarily in immune cells that phosphorylates STAT proteins | Immunodeficiency and autoimmune disease models |
| TYK2 | Tyrosine kinase that contributes to STAT1 and STAT3 phosphorylation | Infectious disease and autoimmunity research |
| STAT1 | Transcription factor phosphorylated on tyrosine in response to interferons | Host defense and pathogen interference studies |
| STAT2 | Transcription factor phosphorylated on tyrosine in type I interferon signaling | Antiviral response research |
| STAT3 | Transcription factor phosphorylated on tyrosine by JAKs and other kinases | Oncogenesis, inflammation, and thrombopoietin signaling |
| STAT4 | Transcription factor phosphorylated on tyrosine in IL-12 signaling | Th1 differentiation and autoimmune models |
| STAT5A | Transcription factor phosphorylated on tyrosine in hematopoietic cytokine signaling | Erythropoiesis and platelet biology |
| STAT5B | Transcription factor phosphorylated on tyrosine in growth hormone and cytokine signaling | Growth and immune function studies |
| STAT6 | Transcription factor phosphorylated on tyrosine in IL-4/IL-13 signaling | Allergy and asthma research |
| EPOR | Erythropoietin receptor that recruits JAK2 to phosphorylate STATs | Erythropoiesis and anemia models |
| THPO | Thrombopoietin ligand that induces STAT3 and STAT5 tyrosine phosphorylation | Platelet production and megakaryopoiesis |
| MPL | Thrombopoietin receptor that activates JAK2-STAT signaling | Myeloproliferative disease research |
| PTPN1 | Protein tyrosine phosphatase that can dephosphorylate STAT proteins | Negative regulation and metabolic disease studies |
| SOCS1 | Suppressor of cytokine signaling that inhibits JAK-STAT tyrosine phosphorylation | Feedback regulation and cancer research |
| SOCS3 | Suppressor of cytokine signaling that attenuates STAT3 phosphorylation | Inflammation and metabolism studies |
How Is tyrosine phosphorylation of STAT protein Regulated?
Tyrosine phosphorylation of STAT proteins is regulated at multiple levels. Receptor engagement and JAK activation provide the primary positive input. Negative regulation is mediated by protein tyrosine phosphatases, SOCS proteins, and protein inhibitors of activated STATs (PIAS), which collectively terminate or dampen the signal. Serine phosphorylation by MAPK pathways can modulate STAT transcriptional activity without being required for tyrosine phosphorylation itself. In addition, pathogen-derived factors can actively inhibit STAT tyrosine phosphorylation, as shown for enterohaemorrhagic Escherichia coli O157:H7, which blocks interferon-gamma-induced STAT-1 tyrosine phosphorylation, an effect prevented by probiotics. This multilayered regulation ensures that STAT activation is transient and context-specific.
tyrosine phosphorylation of STAT protein and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| JAK2 | Myeloproliferative neoplasms and leukemia | Knock-in of JAK2 V617F mutation in hematopoietic cell lines |
| STAT3 | Solid tumors and inflammatory diseases | STAT3 knockout and point-mutant cell models |
| STAT1 | Infectious disease susceptibility and interferonopathies | STAT1 knockout cells challenged with interferon and pathogens |
| STAT5A | Hematopoietic malignancies and platelet disorders | STAT5A knockout and tagged knock-in models |
| SOCS1 | Cancer and autoimmunity due to loss of negative regulation | SOCS1 knockout cells with cytokine stimulation |
Cancer and hematological malignancies
Constitutive activation of JAK kinases or upstream receptors leads to sustained tyrosine phosphorylation of STAT proteins, particularly STAT3 and STAT5, which promotes proliferation and survival of malignant cells. Activating mutations in JAK2 are well-recognized drivers of myeloproliferative neoplasms, and dysregulated STAT tyrosine phosphorylation is a hallmark of many hematological and solid tumors. Because tyrosine phosphorylation is required for functional STAT activation, including in constitutively active mutants, targeting this step is a rational therapeutic strategy.
Infectious disease and host-pathogen interactions
Pathogens can subvert host immunity by interfering with STAT tyrosine phosphorylation. Enterohaemorrhagic Escherichia coli O157:H7 inhibits interferon-gamma-induced tyrosine phosphorylation of STAT-1, thereby blunting antimicrobial responses. Probiotics can prevent this inhibition, highlighting the potential to modulate STAT phosphorylation through microbiome-directed interventions. These findings position GO:0007260 as a key node in host-pathogen interplay.
Immune dysregulation and inflammation
Cytokine signaling through JAK-STAT pathways depends on tyrosine phosphorylation of STAT proteins to drive inflammatory gene expression. Excessive or persistent STAT activation contributes to autoimmune and inflammatory conditions, and JAK inhibitors that reduce STAT tyrosine phosphorylation are used clinically to treat such diseases. Understanding the regulation of this modification is therefore central to immunomodulatory drug development.
Hematopoiesis and platelet biology
Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets, linking GO:0007260 to megakaryopoiesis and platelet function. Erythropoietin-induced STAT serine phosphorylation, which follows tyrosine phosphorylation, is regulated by MAPK pathways and influences erythroid responses. These findings connect STAT tyrosine phosphorylation to normal and pathological blood cell production.
From tyrosine phosphorylation of STAT protein-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a kinase required for STAT tyrosine phosphorylation? | Kinase knockout cell line (e.g., JAK1 or JAK2 KO) |
| Does a specific tyrosine residue on STAT mediate activation? | Point mutation of the STAT tyrosine to phenylalanine (Y-to-F) |
| How does a disease-associated mutation affect STAT phosphorylation? | Knock-in of the patient mutation into the endogenous STAT locus |
| Where and when is phosphorylated STAT localized? | Tagged knock-in of STAT with a fluorescent or epitope tag |
| Does overexpression of a constitutively active STAT drive transformation? | Overexpression of constitutively active STAT mutants |
| Can a compound inhibit STAT tyrosine phosphorylation? | Wild-type cells treated with inhibitors and analyzed by phospho-flow |
How to Study the tyrosine phosphorylation of STAT protein Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phospho-specific immunoblotting | Levels of tyrosine-phosphorylated STAT proteins | Cytokine stimulation and inhibitor studies |
| Flow cytometry with phospho-antibodies | Single-cell STAT phosphorylation | Analysis of heterogeneous immune cell populations |
| Immunoprecipitation | Physical association and modification of STAT proteins | Confirming direct STAT tyrosine phosphorylation |
| CRISPR knockout | Requirement of a gene for STAT phosphorylation | Identifying upstream kinases or regulators |
| Point mutation (Y-to-F) | Necessity of a specific tyrosine residue | Testing STAT activation mechanisms |
| Knock-in tagging | Localization and dynamics of phosphorylated STAT | Imaging and biochemical tracking |
| Reporter gene assay | Transcriptional output downstream of STAT phosphorylation | Measuring functional consequences of STAT activation |
| RNA sequencing | Global gene expression changes | Defining STAT-dependent transcriptional programs |
Phospho-specific immunoblotting and immunoprecipitation
Immunoblotting with antibodies that recognize tyrosine-phosphorylated STAT proteins is the classic method for detecting GO:0007260 activity. Immunoprecipitation of STAT proteins followed by anti-phosphotyrosine blotting provides confirmation of the modification. These methods are widely used to assess cytokine-induced STAT activation and the effects of kinase inhibitors.
Flow cytometric analysis of STAT phosphorylation
Flow cytometry using phospho-specific antibodies allows quantification of STAT tyrosine phosphorylation at the single-cell level. This approach is valuable for analyzing heterogeneous cell populations, such as blood or tumor samples, and for measuring responses to cytokines or drugs. It complements bulk biochemical assays by revealing cell-to-cell variability.
Genetic perturbation with CRISPR
CRISPR knockout of kinases, phosphatases, or STAT genes themselves can establish which components are required for tyrosine phosphorylation of STAT proteins. Point mutations that change the target tyrosine to phenylalanine can test whether a specific residue is necessary for STAT activation. Knock-in of epitope tags enables detection and localization studies.
Transcriptional readouts and pathway profiling
Because tyrosine phosphorylation of STAT proteins leads to transcriptional activation, reporter assays and RNA sequencing of STAT target genes can indirectly measure pathway activity. Combining phospho-protein measurements with transcriptomic profiling provides a comprehensive view of JAK-STAT signaling output.
How CRISPR Can Be Used to Study GO:0007260 tyrosine phosphorylation of STAT protein
Knockout
CRISPR knockout of JAK kinases, STAT genes, or negative regulators such as SOCS1 can reveal which components are essential for tyrosine phosphorylation of STAT proteins. For example, JAK1 or JAK2 knockout cells show loss of cytokine-induced STAT phosphorylation, confirming their non-redundant roles. Knockout of phosphatases can lead to sustained STAT phosphorylation, helping to define negative regulatory circuits.
Point Mutation
CRISPR-mediated point mutation of the conserved tyrosine residue in a STAT protein to phenylalanine prevents its phosphorylation and blocks downstream activation. This approach is used to test whether a specific tyrosine is required for STAT dimerization, nuclear translocation, and transcriptional activity. Point mutations can also be introduced into kinase domains to dissect catalytic requirements.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous STAT loci allows direct detection and imaging of tyrosine-phosphorylated STAT proteins in live cells. Disease-associated mutations, such as JAK2 V617F, can be knocked into cell lines to model constitutive STAT phosphorylation. Knock-in models preserve endogenous regulatory sequences, providing physiologically relevant readouts.
Overexpression
Overexpression of wild-type or constitutively active STAT mutants can drive ligand-independent tyrosine phosphorylation and transformation. Such models are useful for testing whether tyrosine phosphorylation is required for the functional activity of constitutively active STAT proteins, as shown for disulfide-containing mutants. Overexpression of JAK kinases can also amplify STAT phosphorylation for biochemical studies.
How EDITGENE Supports tyrosine phosphorylation of STAT protein Research
Researchers studying tyrosine phosphorylation of STAT protein-related genes often need to determine whether a candidate gene is causally involved in STAT activation, whether a specific tyrosine residue is required, or how a disease-associated mutation alters signaling. EDITGENE provides CRISPR-based cell model services that enable precise, reproducible experiments to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for tyrosine phosphorylation of STAT protein research.
Frequently Asked Questions About tyrosine phosphorylation of STAT protein
What is tyrosine phosphorylation of STAT protein?
It is the covalent addition of a phosphate group to a tyrosine residue of a STAT protein, a key step in cytokine signaling that activates STAT transcription factors.
What genes are involved in tyrosine phosphorylation of STAT protein?
JAK kinases (JAK1, JAK2, JAK3, TYK2) and STAT family members (STAT1-STAT6) are the principal genes, along with cytokine receptors and phosphatases.
Which enzymes phosphorylate STAT proteins on tyrosine?
Janus kinases (JAKs) are the primary enzymes that phosphorylate STAT proteins on tyrosine residues downstream of cytokine receptors.
Why is tyrosine phosphorylation important for STAT function?
It is required for STAT dimerization, nuclear translocation, and transcriptional activation, and it is necessary for the functional activity of constitutively active STAT mutants.
How is STAT tyrosine phosphorylation measured?
It is commonly measured by phospho-specific immunoblotting, immunoprecipitation, and flow cytometry with phospho-antibodies.
Does serine phosphorylation affect STAT tyrosine phosphorylation?
Serine phosphorylation by MAPK pathways can modulate STAT transcriptional activity and promoter complex formation, but it is distinct from the tyrosine phosphorylation event defined by GO:0007260.
Can pathogens inhibit STAT tyrosine phosphorylation?
Yes, enterohaemorrhagic Escherichia coli O157:H7 inhibits interferon-gamma-induced tyrosine phosphorylation of STAT-1, and probiotics can prevent this inhibition.
What diseases are linked to abnormal STAT tyrosine phosphorylation?
Cancer, hematological malignancies, immune dysregulation, and infectious disease complications are linked to dysregulated STAT tyrosine phosphorylation.
What is the GO ID for tyrosine phosphorylation of STAT protein?
The GO ID is GO:0007260.
How can CRISPR help study STAT tyrosine phosphorylation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test which genes and residues are required for STAT tyrosine phosphorylation and its downstream effects.
Conclusion
GO:0007260, tyrosine phosphorylation of STAT protein, is a central post-translational event that converts cytokine and growth factor signals into transcriptional programs controlling immunity, proliferation, and differentiation. Its requirement for STAT activation, including in constitutively active mutants, makes it a critical node for both mechanistic studies and therapeutic targeting. Dysregulation of this process is implicated in cancer, immune disorders, and host-pathogen interactions, underscoring its biomedical importance. Advances in phospho-flow cytometry and CRISPR-based models continue to refine our understanding of how this modification is controlled and how it can be manipulated.
References
- 1. Agashe RP et al.. 2022. JAK: Not Just Another Kinase.. Mol Cancer Ther 21(12):1757-1764 PMID: 36252553
- 2. Haq R et al.. 2002. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.. J Biol Chem 277(19):17359-66 PMID: 11875080
- 3. Decker T et al.. 2000. Serine phosphorylation of STATs.. Oncogene 19(21):2628-37 PMID: 10851062
- 4. Miyakawa Y et al.. 1996. Thrombopoietin induces tyrosine phosphorylation of Stat3 and Stat5 in human blood platelets.. Blood 87(2):439-46 PMID: 8555464
- 5. Liddle FJ et al.. 2006. Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutants.. Biochemistry 45(17):5599-605 PMID: 16634641
- 6. Murphy J et al.. 2013. Flow cytometric analysis of STAT phosphorylation.. Methods Mol Biol 967:161-5 PMID: 23296728
- 7. Zhang X et al.. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes.. Science 267(5206):1990-4 PMID: 7701321
- 8. Jandu N et al.. 2009. Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1.. Microbiology (Reading) 155(Pt 2):531-540 PMID: 19202101
